Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DYNAVAX TECHNOLOGIES CORP Director's Dealing 2012

Dec 19, 2012

32130_dirs_2012-12-19_bc7b3b4d-7c2f-4b1e-9aff-e861ec9c608b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DYNAVAX TECHNOLOGIES CORP (DVAX)
CIK: 0001029142
Period of Report: 2012-12-18

Reporting Person: COFFMAN ROBERT (Chief Scientific Officer & VP)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-12-18 Common Stock M 19926 $1.50 Acquired 57918 Direct
2012-12-18 Common Stock F 10451 $2.86 Disposed 47467 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-12-18 Stock Option $1.50 M 19926 Disposed 2013-01-21 Common Stock (19926) Direct

Footnotes

F1: On December 18, 2012, Dr. Coffman exercised certain of his outstanding options to purchase 19,926 shares. As consideration for the purchase price, Dr. Coffman delivered 10,451 shares to the Company. No shares were sold in the market in connection with this exercise.

F2: This Stock Option was granted on January 22, 2003 with an expiration of January 21, 2013 and vested over a four-year period after the date of the grant.

F3: Not applicable.